Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...
Cautionary Language Concerning Forward-Looking Statements ...
MyChesCo on MSN
Inhibikase enrolls first patient in phase 3 PAH trial
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) has enrolled the first patient in its Phase 3 clinical trial ...
Glasgow Times on MSN
New cancer treatments approved for NHS Scotland in major medicine update
Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...
Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results